A Universal Correction Strategy for α-Thalassemia Using CRISPR/AAV-Mediated Genome Editing

被引:0
作者
Cromer, M. Kyle [1 ]
Wienert, Beeke [2 ]
Hampton, Jessica P. [1 ]
Majeti, Kiran R. [1 ]
Conklin, Bruce R. [2 ]
Porteus, Matthew H. [1 ]
MacKenzie, Tippi C. [3 ]
机构
[1] Stanford Univ, Pediat, Stanford, CA 94305 USA
[2] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Surg, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
696
引用
收藏
页码:328 / 328
页数:1
相关论文
共 50 条
[31]   Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII [J].
Marcos-Contreras, Oscar A. ;
Smith, Shannon M. ;
Bellinger, Dwight A. ;
Raymer, Robin A. ;
Merricks, Elizabeth ;
Faella, Armida ;
Pavani, Giulia ;
Zhou, Shangzhen ;
Nichols, Timothy C. ;
High, Katherine A. ;
Margaritis, Paris .
BLOOD, 2016, 127 (05) :565-571
[32]   AAV-mediated gene editing of type 1 collagen mutation for Osteogenesis Imperfecta [J].
Yang, Yeon-Suk ;
Sato, Tadatoshi ;
Chaugule, Sachin ;
Chen, Zhihao ;
Rodriguez, Agustina ;
Ma, Hong ;
Xie, Jun ;
Gao, Guangping ;
Shim, Jae-Hyuck .
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 :232-233
[33]   Somatic Genome Editing in Murine Lung via AAV Delivery of CRISPR [J].
Chen, Honglin ;
Liang, Yuxin ;
Foreman, Oded ;
Caplazi, Patrick ;
Warming, Soren ;
Haley, Benjamin .
MOLECULAR THERAPY, 2020, 28 (04) :133-133
[34]   AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma [J].
Ryan D Chow ;
Christopher D Guzman ;
Guangchuan Wang ;
Florian Schmidt ;
Mark W Youngblood ;
Lupeng Ye ;
Youssef Errami ;
Matthew B Dong ;
Michael A Martinez ;
Sensen Zhang ;
Paul Renauer ;
Kaya Bilguvar ;
Murat Gunel ;
Phillip A Sharp ;
Feng Zhang ;
Randall J Platt ;
Sidi Chen .
Nature Neuroscience, 2017, 20 :1329-1341
[35]   AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma [J].
Chow, Ryan D. ;
Guzman, Christopher D. ;
Wang, Guangchuan ;
Schmidt, Florian ;
Youngblood, Mark W. ;
Ye, Lupeng ;
Errami, Youssef ;
Dong, Matthew B. ;
Martinez, Michael A. ;
Zhang, Sensen ;
Renauer, Paul ;
Bilguvar, Kaya ;
Gunel, Murat ;
Sharp, Phillip A. ;
Zhang, Feng ;
Platt, Randall J. ;
Chen, Sidi .
NATURE NEUROSCIENCE, 2017, 20 (10) :1329-+
[36]   Correction to: Recent advances in CRISPR technologies for genome editing [J].
Myeonghoon Song ;
Taeyoung Koo .
Archives of Pharmacal Research, 2021, 44 :836-838
[37]   MILESTONE, A universal CRISPR/Cas9n-mediated genome editing strategy for ELANE-related severe congenital neutropenia [J].
Nasri, M. ;
Ritter, M. ;
Mir, P. ;
Dannenmann, B. ;
Kaufmann, M. M. ;
Xu, Y. ;
Borbaran-Bravo, N. ;
Klimiankou, M. ;
Lengerke, C. ;
Zeidler, C. ;
Cathomen, T. ;
Welte, K. ;
Skokowa, J. .
HUMAN GENE THERAPY, 2024, 35 (3-4) :A8-A9
[38]   Generation of an in vitro model of β-thalassemia using the CRISPR/Cas9 genome editing system [J].
Ajami, Monireh ;
Atashi, Amir ;
Kaviani, Saeid ;
Kiani, Jafar ;
Soleimani, Masoud .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (02) :1420-1430
[39]   CRISPR/Cas9-mediated genome editing for correction of inherited retinal disease mutations [J].
Burnight, Erin R. ;
Wiley, Luke A. ;
DeLuca, Adam P. ;
Oppedal, Douglas I. ;
Scheetz, Todd E. ;
Mullins, Robert F. ;
Stone, Edwin M. ;
Tucker, Budd A. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[40]   CRISPR-mediated genome editing and human diseases [J].
Cai, Liquan ;
Fisher, Alfred L. ;
Huang, Haochu ;
Xie, Zijian .
GENES & DISEASES, 2016, 3 (04) :244-251